Home/Filings/4/0001737287-25-000071
4//SEC Filing

Kazam Joshua A 4

Accession 0001737287-25-000071

CIK 0001737287other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 9:03 PM ET

Size

311.4 KB

Accession

0001737287-25-000071

Insider Transaction Report

Form 4
Period: 2025-06-18
Transactions
  • Award

    Restricted Stock Unit

    2025-06-18+94,50094,500 total
    Common Stock (94,500 underlying)
Footnotes (1)
  • [F1]Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date.

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1
  • filerCIK 0001221355

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 9:03 PM ET
Size
311.4 KB